Skip to main content

Haemophilus influenzae type b Conjugate Vaccine

Product overview

Type
Haemophilus influenzae type b
Commercial Name
Haemophilus influenzae type b Conjugate Vaccine
Manufacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial
Number of Doses
1
Diluent
0.4% Nacl ampoule
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a. Carton of 50 vials (active)(50 doses) [Dimensions 18.5x9.5x6.0 cm] + b. Carton of 50 ampoules (diluent)(50 doses) [Dimensions 14.5x6.0x7.2 cm]
Tertiary Packaging
Box of 24 cartons of 50 vials (1200 vials/1200 doses) [Dimensions 60x48x41 cm]; Box of 24 cartons of 50 ampoules (1200 ampoules/1200 doses) [Dimensions 60x48x41 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
a. 21.09 (vial); b.12.528(ampoule) cm3/dose (in secondary packaging)

Attachments

Container Photo
Package Insert